Talacotuzumab
CAS No. 1826831-79-1
Talacotuzumab( —— )
Catalog No. M36759 CAS No. 1826831-79-1
Talacotuzumab (JNJ 56022473) is an IgG1 fully humanized CD123 neutralizing monoclonal antibody containing a modified Fc structure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 943 | In Stock |
|
| 10MG | 1311 | In Stock |
|
| 25MG | 1881 | In Stock |
|
| 50MG | 2623 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTalacotuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionTalacotuzumab (JNJ 56022473) is an IgG1 fully humanized CD123 neutralizing monoclonal antibody containing a modified Fc structure.
-
DescriptionTalacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models.
-
In Vitro——
-
In VivoAnimal Model:Nonobese diabetic/severe combined immunodeficiency mice injected intravenously AML xenograft cells (AML-5)Dosage:300 μg Administration:IP; thrice weekly for 5 weeks Result:Resulted in a significant delay in tumor growth compared with an isotype control.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorInterleukin | Immunology/Inflammation related
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1826831-79-1
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. S J Busfield, et al. Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC. Leukemia. 2014 Nov;28(11):2213-21.?
molnova catalog
related products
-
Glycyrrhetinic acid
Enoxolone (INN, BAN; also known as glycyrrhetinic acid) is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid.
-
Flumetsulam
Flumetsulam is a triazolopyrimidine herbicide.
-
Motilin (human, porc...
Motilin, human, porcine is a gastrointestinal hormone, which is released during fasting and after eating, or by drinking water. Motilin, human, porcine promotes enteric cholinergic activity in human stomach with an EC50 of 33 nM, and thus modulates gastrointestinal motility function.
Cart
sales@molnova.com